Weekly Tech+Bio Highlights #50: How Robust Are Pathology Foundation Models?
CRISPR-GPT, Current Gene Delivery Landscape, & Thought-Controlled iPad
Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.
If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button:
Updates in AI-driven biotech and neurote…